Whalerock Point Partners’s Amgen AMGN Stock Holding History

Whalerock Point Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$460K	Hold	1,306	–	–	0.09%	130
2025 Q4	$427K	Sell	1,306 -100	-7%	-$31.7K	0.08%	131
2025 Q3	$397K	Sell	1,406 -46	-3%	-$13.3K	0.08%	121
2025 Q2	$405K	Hold	1,452	–	–	0.09%	127
2025 Q1	$452K	Sell	1,452 -503	-26%	-$149K	0.11%	113
2024 Q4	$510K	Sell	1,955 -92	-4%	-$27.3K	0.12%	99
2024 Q3	$660K	Hold	2,047	–	–	0.16%	90
2024 Q2	$640K	Hold	2,047	–	–	0.17%	82
2024 Q1	$582K	Sell	2,047 -100	-5%	-$29.3K	0.16%	93
2023 Q4	$618K	Sell	2,147 -200	-9%	-$54.5K	0.19%	83
2023 Q3	$631K	Hold	2,347	–	–	0.22%	76
2023 Q2	$521K	Buy	2,347 +70	+3%	+$16.2K	0.18%	84
2023 Q1	$550K	Hold	2,277	–	–	0.2%	74
2022 Q4	$598K	Buy	2,277 +46	+2%	+$12.3K	0.24%	71
2022 Q3	$503K	Hold	2,231	–	–	0.22%	73
2022 Q2	$543K	Sell	2,231 -500	-18%	-$123K	0.23%	72
2022 Q1	$660K	Hold	2,731	–	–	0.23%	73
2021 Q4	$614K	Sell	2,731 -380	-12%	-$80.2K	0.21%	79
2021 Q3	$662K	Sell	3,111 -50	-2%	-$11.5K	0.26%	72
2021 Q2	$770K	Hold	3,161	–	–	0.3%	64
2021 Q1	$786K	Hold	3,161	–	–	0.35%	59
2020 Q4	$727K	Buy	3,161 +2,358	+294%	+$544K	0.35%	59
2020 Q3	$803K	Sell	803 -2,390	-75%	-$592K	0.44%	56
2020 Q2	$753K	Sell	3,193 -370	-10%	-$84.4K	0.44%	57
2020 Q1	$722K	Sell	3,563 -1,005	-22%	-$220K	0.52%	54
2019 Q4	$1.1M	Sell	4,568 -1	-0%	-$220	0.59%	49
2019 Q3	$884K	Sell	4,569 -188	-4%	-$36.1K	0.48%	56
2019 Q2	$877K	Sell	4,757 -245	-5%	-$43.9K	0.5%	53
2019 Q1	$950K	Buy	5,002 +2,489	+99%	+$475K	0.62%	47
2018 Q4	$489K	Sell	2,513 -1,198	-32%	-$234K	0.46%	53
2018 Q3	$769K	Sell	3,711 -37	-1%	-$7.29K	0.56%	47
2018 Q2	$692K	Sell	3,748 -7,500	-67%	-$1.33M	0.55%	49
2018 Q1	$1.92M	Buy	11,248 +2,067	+23%	+$379K	0.61%	32
2017 Q4	$1.6M	Buy	9,181 +1,704	+23%	+$302K	0.51%	41
2017 Q3	$1.39M	Buy	7,477 +553	+8%	+$98K	0.49%	44
2017 Q2	$1.19M	Sell	6,924 -15	-0.2%	-$2.44K	0.44%	49
2017 Q1	$1.14M	Buy	6,939 +592	+9%	+$98.4K	0.42%	49
2016 Q4	$928K	Buy	6,347 +238	+4%	+$35.8K	0.37%	52
2016 Q3	$1.02M	Buy	+6,109	New	+$1.03M	0.42%	45
2016 Q1	$892K	Buy	5,959 +70	+1%	+$10.4K	0.38%	47
2015 Q4	$955K	Buy	5,889 +1,500	+34%	+$236K	0.42%	48
2015 Q3	$607K	Buy	4,389 +617	+16%	+$97.3K	0.26%	75
2015 Q2	$579K	Buy	3,772 +347	+10%	+$55.6K	0.24%	76
2015 Q1	$547K	Hold	3,425	–	–	0.22%	84
2014 Q4	$545K	Buy	3,425 +560	+20%	+$87.3K	0.23%	76
2014 Q3	$402K	Sell	2,865 -340	-11%	-$44.4K	0.18%	94
2014 Q2	$379K	Buy	3,205 +615	+24%	+$71.2K	0.18%	93
2014 Q1	$319K	Buy	2,590 +100	+4%	+$12.1K	0.16%	93
2013 Q4	$284K	Buy	+2,490	New	+$283K	0.15%	95

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Whalerock Point Partners's AMGN Position: Q1 2026 in Review

Whalerock Point Partners held its Amgen (AMGN) position steady in Q1 2026 at 1,306 shares worth $460K. The position accounts for 0.09% of the portfolio, ranked #130.

Whalerock Point Partners first reported a position in AMGN in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.92M in Q1 2018. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Whalerock Point Partners held 1,306 shares of Amgen worth $460K as of Q1 2026.
Whalerock Point Partners left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.09% of Whalerock Point Partners's portfolio in Q1 2026, its #130 holding.
Whalerock Point Partners first reported a position in Amgen in Q4 2013 and has held it in 49 quarters since.
Whalerock Point Partners's Amgen position peaked at $1.92M in Q1 2018.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.